Review
Copyright ©The Author(s) 2015.
World J Hepatol. Aug 18, 2015; 7(17): 2069-2079
Published online Aug 18, 2015. doi: 10.4254/wjh.v7.i17.2069
Table 2 Diagnostic performance of magnetic resonance elastography for hepatic fibrosis
Ref.YearStudy methodImaging instrumentEtiologiesNo. of patientsSensitivity (%)Specificity (%)Cut-offsAUROCFibrosis score
Singh et al[66]2015Meta-analysis1.5 Tesla, variableChronic viral and nonviralhepatopathies69779813.66 kPa0.88≥ F2
Venkatesh et al[67]2015Retrospective1.5 Tesla, (GE, Signa)Chronic viral and nonviralhepatopathies6210096.53.37 kPa0.99≥ F2
Yoon et al[56]2014Prospective1.5 Tesla (GE, SignaHDx)Chronic viral and nonviralhepatopathies9478.875.66.65 kPa0.852≥ F2
Venkatesh et al[68]2014Prospective1.5 Tesla (GE, Signa)HBV6397.41003.2 kPa0.99≥ F2
Shi et al[69]2014Prospective3.0 Tesla (GE, Signa Excite HD)HBV1139594.54.07 kPa0.986≥ F2
Loomba et al[70]2014Prospective3.0 Tesla (GE, Signa Excite HD)Nonalcoholic fatty liver disease11786913.63 kPa0.924≥ F3
Bohte et al[71]2014Prospective3.0 Tesla (Philips, Intera)HBV, HCV10362962.18 kPa0.928≥ F2
Kim et al[72]2013Retrospective1.5 Tesla (GE, Signa)Nonalcoholic fatty liver disease1428592.94.15 kPa0.954≥ F3
Wang et al[73]2012Meta-analysis1.5 Tesla, variableChronic viral and nonviralhepatopathies9729495N/A0.98≥ F2
Rustogi et al[54]2012Retrospective1.5 Tesla (Siemens, Magnetom)Chronic viral and nonviralhepatopathies7285.488.45.9 kPaN/A≥ F3
Kim et al[74]2011Prospective1.5 Tesla GE, SignaHDx)Chronic viral and nonviralhepatopathies5589.787.13.05 kPaN/A≥ F2